益气活血软坚解毒方对荷H22 615小鼠肝癌细胞凋亡相关基因Fas、FasL、Bcl-2、Bax、P^53、NF-κB表达的影响
李东涛, 孙桂芝, 吴志奎, Li Jie, 吕新霞, 陈玉英, 裴迎霞, 祁鑫
Abstract
李东涛, 孙桂芝, 吴志奎, Li Jie, 吕新霞, 陈玉英, 裴迎霞, 祁鑫
Abstract
Objective: To study the effect of Yiqi, Huoxue, Ruanjian & Jiedu (YHRJ) Recipe on the expression of heaptocarcinoma cell, apoptosis regulate gene such as Fas, FasL, Bcl-2, Bax, P^53, NF-κB in mice with H22 615 Tumor. Methods: The mice were randomly divided into 6 groups: NS group, DDP group, YHRJ equivalent dosage group, YHRJ high dosage group, YHRJ equivalent dosage +DDP group, YHRJ high dosage +DDP group. Immunohistochemistry, situhybridization and RT-PCR were used to detect the key regulator genes of HCC apoptosis, Fas, FasL, Bcl-2, Bax, P^53, NF-κB protein and mRNA in mice with H22 615 tumor after 13 days treatment. Results: The immunohistochemistry results showed: compared with NS group, each adding medicine group could enhance the expression of Fas protein (P<0.01) and YHRJ equivalent dosage +DDP group could decrease obviously the expression of FasL protein (P<0.01). Compared with DDP group, Chinese medicines groups and Chinese medicines +DDP groups could decrease obviously the expression of FasL protein (P<0.01). Compared with NS group, each adding medicine group could decrease obviously the expression of NF-κB protein (P<0.05 or P<0.01); Compared with DDP group, YHRJ equivalent dosage group, YHRJ high dosage group, YHRJ high dosage +DDP group could decrease obviously the expression of NF-κB protein (P<0.01). Compared with NS group, each adding medicine group could decrease obviously the expression of mutated P^53 protein (P<0.01); Compared with DDP group, Chinese medicines groups and Chinese medicines +DDP groups could decrease obviously the expression of mutated P^53 protein (P<0.01). Compared with NS group, each adding medicine group could enhance obviously the expression of Bax protein (P<0.01); Compared with DDP group, YHRJ high dosage group and Chinese medicines +DDP groups could enhance obviously the expression of Bax protein (P<0.01). The situhybridization detect the expression of results NF-κB mRNA, the results showed: compared with NS group and DDP group, YHRJ equivalent dosage group and Chinese medicines +DDP groups could decrease obviously the expression of NF-κB mRNA (P<0.01). The RT-PCR detect the expression of Bax, Bcl-2 mRNA, the results showed: compared with NS group and DDP group, YHRJ equivalent dosage group could enhance obviously the expression of Bax mRNA (P<0.001). Compared with NS group, each adding medicine group could decrease obviously the expression of Bcl-2 mRNA (P<0.05 or P<0.001). Compared with DDP group, YHRJ high dosage group could decrease obviously the expression of Bcl-2 mRNA (P=0.01). Conclusion: YHRJ recipe could accelerate the apoptosis of HCC in mice with H22615 tumor, and enhance the gene expression of Fas and Bax, and decrease the expression of FasL and Bcl-2 (the restrain apoptosis genes), and decrease the expression of mutated P^53 (a apoptosis protection gene) protein and NF-κB gene. These roles are elements underlying to induce the HCC cells apoptosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the effect of Yiqi, Huoxue, Ruanjian & Jiedu (YHRJ) Recipe on the expression of heaptocarcinoma cell, apoptosis regulate gene such as Fas, FasL, Bcl-2, Bax, P^53, NF-κB in mice with H22 615 Tumor. Methods: The mice were randomly divided into 6 groups: NS group, DDP group, YHRJ equivalent dosage group, YHRJ high dosage group, YHRJ equivalent dosage +DDP group, YHRJ high dosage +DDP group. Immunohistochemistry, situhybridization and RT-PCR were used to detect the key regulator genes of HCC apoptosis, Fas, FasL, Bcl-2, Bax, P^53, NF-κB protein and mRNA in mice with H22 615 tumor after 13 days treatment. Results: The immunohistochemistry results showed: compared with NS group, each adding medicine group could enhance the expression of Fas protein (P<0.01) and YHRJ equivalent dosage +DDP group could decrease obviously the expression of FasL protein (P<0.01). Compared with DDP group, Chinese medicines groups and Chinese medicines +DDP groups could decrease obviously the expression of FasL protein (P<0.01). Compared with NS group, each adding medicine group could decrease obviously the expression of NF-κB protein (P<0.05 or P<0.01); Compared with DDP group, YHRJ equivalent dosage group, YHRJ high dosage group, YHRJ high dosage +DDP group could decrease obviously the expression of NF-κB protein (P<0.01). Compared with NS group, each adding medicine group could decrease obviously the expression of mutated P^53 protein (P<0.01); Compared with DDP group, Chinese medicines groups and Chinese medicines +DDP groups could decrease obviously the expression of mutated P^53 protein (P<0.01). Compared with NS group, each adding medicine group could enhance obviously the expression of Bax protein (P<0.01); Compared with DDP group, YHRJ high dosage group and Chinese medicines +DDP groups could enhance obviously the expression of Bax protein (P<0.01). The situhybridization detect the expression of results NF-κB mRNA, the results showed: compared with NS group and DDP group, YHRJ equivalent dosage group and Chinese medicines +DDP groups could decrease obviously the expression of NF-κB mRNA (P<0.01). The RT-PCR detect the expression of Bax, Bcl-2 mRNA, the results showed: compared with NS group and DDP group, YHRJ equivalent dosage group could enhance obviously the expression of Bax mRNA (P<0.001). Compared with NS group, each adding medicine group could decrease obviously the expression of Bcl-2 mRNA (P<0.05 or P<0.001). Compared with DDP group, YHRJ high dosage group could decrease obviously the expression of Bcl-2 mRNA (P=0.01). Conclusion: YHRJ recipe could accelerate the apoptosis of HCC in mice with H22615 tumor, and enhance the gene expression of Fas and Bax, and decrease the expression of FasL and Bcl-2 (the restrain apoptosis genes), and decrease the expression of mutated P^53 (a apoptosis protection gene) protein and NF-κB gene. These roles are elements underlying to induce the HCC cells apoptosis.
Key concepts: Fas ligand, Apoptosis, Immunohistochemistry, Traditional Chinese medicine, Group A, BAX Protein, Chemistry, Protein expression